Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

The Dow Jones Industrial Average (DJINDICES: ^DJI) index edged 3.9% higher in May, with 70% of its 30 constituent stocks ...

Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...

Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC’s Advisory Committee on Immunization Practices on ...

Among the eight people Robert F. Kennedy Jr. announced would make up his new group of outside vaccine advisers to the US ...

During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.

A former Harvard Medical School professor who claims he was fired for refusing to receive the Covid-19 vaccine was appointed ...

Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

Wall Street's major averages opened lower on Thursday. Investors will keep an eye out for tariff announcements in the coming weeks. See more updates here.

The new project voted ahead by township officials Monday night is planned for roughly a block east, in the Merck campus on ...